<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="0" ids="31941">Oxaliplatin</z:chebi> is effective in advanced <z:e sem="disease" ids="C1527249,C0009402" disease_type="Neoplastic Process" abbrv="">colorectal cancer</z:e> and is known to have relatively few side effects, such as <z:mp ids='MP_0010163'>hemolysis</z:mp> and renal toxicity </plain></SENT>
<SENT sid="1" pm="."><plain>We report a case of <z:hpo ids='HP_0001919'>acute kidney injury</z:hpo> (AKI) after treatment with a combination of <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi>, folinic acid and <z:chebi fb="0" ids="46345">5-fluorouracil</z:chebi> or <z:chebi fb="0" ids="31348">capecitabine</z:chebi> </plain></SENT>
<SENT sid="2" pm="."><plain>The patient developed <z:hpo ids='HP_0001919'>acute renal failure</z:hpo>, <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> and <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> after the 34th course of chemotherapy including <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> </plain></SENT>
<SENT sid="3" pm="."><plain>A positive direct antiglobulin test and detection of immunoglobulin G and complement C3b and C3d on erythrocytes suggested the diagnosis of immune-related severe intravascular <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo> </plain></SENT>
<SENT sid="4" pm="."><plain>She was successfully treated and recovered using plasma exchange, <z:chebi fb="0" ids="50858">corticosteroids</z:chebi> and hemodialysis therapy </plain></SENT>
<SENT sid="5" pm="."><plain>Only seven other cases of AKI associated with <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> use have been reported to date </plain></SENT>
<SENT sid="6" pm="."><plain>As in this case, <z:hpo ids='HP_0011009'>acute</z:hpo> <z:mp ids='MP_0010163'>hemolysis</z:mp> due to autoimmune mechanisms and subsequent AKI occurred suddenly after frequent use of <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> in four of those cases </plain></SENT>
<SENT sid="7" pm="."><plain>We should be aware that <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> may cause sudden life-threatening <z:mp ids='MP_0010163'>hemolysis</z:mp> by drug-induced antibodies and subsequent AKI, even though <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> is frequently administered without side effects </plain></SENT>
<SENT sid="8" pm="."><plain>This represents the first case report of AKI-related <z:mp ids='MP_0010163'>hemolysis</z:mp> due to <z:chebi fb="0" ids="31941">oxaliplatin</z:chebi> in Japan </plain></SENT>
</text></document>